ARGIENTO, LORENZO
ARGIENTO, LORENZO
Universita' degli Studi di MILANO
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score
2026 L. Canova, E. Alimenti, L. Argiento, G. Cabibbo, F. Tovoli, E. Di Giacomo, P. Galle, C. Celsa, M. Pinter, T. Marron, C. Vivaldi, A. Dalbeni, F. Marra, A. Palloni, S. Lonardi, F. Ponziani, P. Federico, A. Saeed, A. Pillai, T. Pressiani, S. Camera, G. Svegliati-Baroni, G. Manfredi, L. Lani, J. Von Felden, S. Ulahannan, L. Ielasi, S. De Lorenzo, C. Mazzarelli, R. Sacco, N. Rohlen, M. Silletta, P. Toniutto, S. Ascari, C. Fulgenzi, B. Scheiner, F. Crowley, F. Cerini, P. Lampertico, D. Pinato, M. Iavarone
Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease
2022 A. Sonaglioni, F. Cerini, A. Cerrone, L. Argiento, G.L. Nicolosi, E. Rigamonti, M. Lombardo, M.G. Rumi, M. Viganò
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score | 2026 | Canova LAlimenti EArgiento LCerini FLampertico PIavarone M. + | Article (author) | - | |
| Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease | 2022 | Cerini, FedericaCerrone, AntonioArgiento, LorenzoLombardo, MicheleRumi, Maria Grazia + | Article (author) | - |